Dyspnea Clinical Trial - Walking Football for People With Chronic

Status Completed

Clinical Trial Summary

The objective of this study is to evaluate the feasibility of a walking football intervention for people with chronic breathlessness. Chronic breathlessness refers to breathlessness that persists despite optimal treatment of the underlying pathophysiology. Roughly 9-13% of the general population will experience chronic breathlessness, with incidence rising with age to 37% for those aged over 60years. This mixed-methods study will offer patients who have enrolled on to pulmonary rehabilitation (PR) the prospect to partake in walking football once they have completed their scheduled programmes (or voluntarily dropped-out); introducing a potential opportunity for long-term exercise maintenance post PR. Participants will be recruited from North Tees & Hartlepool Foundation Trust, and South Tees Foundation Trust. PR is recommended for all people with chronic breathlessness and has been shown to improve exercise capacity and health-related quality of life. However, PR programmes typically only last for 6-12 weeks, and have little to no impact on long-term physical activity levels. Walking Football has been identified as a potential form of exercise which people with breathlessness could maintain post-PR, thus offering a solution to PRs limited ability to promote exercise maintenance. Participants will be invited to play walking football for 6-weeks (2-hours weekly) in the Middlesbrough/Stockton area. Before and after weeks 1 and 6, breathlessness-relevant outcomes will be measured including; exercise capacity, lower-limb strength, perceived breathlessness, quality of life, balance confidence, depression, and anxiety. During a participant's third session, one-time physical intensity outcomes will be calculated during play including heart-rate and perceived intensity. Participants will also be invited to an interview to discuss how feasible they have found the football, any benefits they may have experienced, and how the football programme could be improved. The study will officially end with a co-production workshop; a focus group with stakeholders (players, physiotherapists, co-ordinators, researchers) after preliminary analysis has been conducted to discuss initial findings.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Dyspnea

Clinical Trial Details

NCT number	NCT05575102
Study type	Interventional
Source	Teesside University
Contact
Status	Completed
Phase	N/A
Start date	March 22, 2023
Completion date	December 13, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04688905` - Diagnosing Heart Failure With Preserved Ejection Fraction in Patients With Unexplained Dyspnea (Diagnose-HFpEF)
Completed	`NCT03679312` - The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD	Phase 1/Phase 2
Recruiting	`NCT04868357` - Hypnosis for the Management of Anxiety and Breathlessness During a Pulmonary Rehabilitation Program	N/A
Active, not recruiting	`NCT03604822` - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS	N/A
Completed	`NCT03626519` - Effects of Menthol on Dyspnoea in COPD Patients	N/A
Completed	`NCT02638649` - Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
Terminated	`NCT02269761` - Chest Ultrasound of ER Patients With Cough or SOB
Completed	`NCT02538770` - Rapid Viral Diagnostics in Adults to Reduce Antimicrobial Consumption and Duration of Hospitalization	N/A
Completed	`NCT02248831` - Evaluation of Cardiopulmonary Diseases by Ultrasound	N/A
Recruiting	`NCT01655199` - Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease	N/A
Active, not recruiting	`NCT01440764` - Aerosol Inhalation Treatment for Dyspnea	Phase 1/Phase 2
Completed	`NCT01577407` - Non Opioid Treatment for Experimental Dyspnea	Phase 3
Completed	`NCT01193998` - Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department	N/A
Recruiting	`NCT04327882` - Point-of-care Ultrasound Interest in Dyspneic Emergency Department Patients: an Observational Bicentric Study
Completed	`NCT05029986` - Preventing Dyspnea During Speech in Older Speakers	N/A
Not yet recruiting	`NCT04181359` - The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in Interstitial Lung Disease.	Phase 1/Phase 2
Recruiting	`NCT04615065` - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Completed	`NCT04305639` - The Reliability and Validity of Turkish Version of ''The Dyspnea-ALS-Scale (DALS-15)"
Completed	`NCT04370990` - Automated Oxygen Administration -Rethinking Interventions Alleviating Dyspnea in Patients With COPD	N/A
Completed	`NCT04375917` - Is Reduced Hypoxia Through a Robot Intervention, Associated With Sensory and Emotional Descriptions of Dyspnea, Anxiety, Depression, Symptom Burden and Anxiolytics	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Walking Football for People With Chronic Breathlessness

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms